Cargando…

Signalling to eIF4E in cancer

Translational control plays a critical role in the regulation of gene expression in eukaryotes and affects many essential cellular processes, including proliferation, apoptosis and differentiation. Under most circumstances, translational control occurs at the initiation step at which the ribosome is...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Nadeem, Sonenberg, Nahum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613458/
https://www.ncbi.nlm.nih.gov/pubmed/26517881
http://dx.doi.org/10.1042/BST20150126
_version_ 1782396281474252800
author Siddiqui, Nadeem
Sonenberg, Nahum
author_facet Siddiqui, Nadeem
Sonenberg, Nahum
author_sort Siddiqui, Nadeem
collection PubMed
description Translational control plays a critical role in the regulation of gene expression in eukaryotes and affects many essential cellular processes, including proliferation, apoptosis and differentiation. Under most circumstances, translational control occurs at the initiation step at which the ribosome is recruited to the mRNA. The eukaryotic translation initiation factor 4E (eIF4E), as part of the eIF4F complex, interacts first with the mRNA and facilitates the recruitment of the 40S ribosomal subunit. The activity of eIF4E is regulated at many levels, most profoundly by two major signalling pathways: PI3K (phosphoinositide 3-kinase)/Akt (also known and Protein Kinase B, PKB)/mTOR (mechanistic/mammalian target of rapamycin) and Ras (rat sarcoma)/MAPK (mitogen-activated protein kinase)/Mnk (MAPK-interacting kinases). mTOR directly phosphorylates the 4E-BPs (eIF4E-binding proteins), which are inhibitors of eIF4E, to relieve translational suppression, whereas Mnk phosphorylates eIF4E to stimulate translation. Hyperactivation of these pathways occurs in the majority of cancers, which results in increased eIF4E activity. Thus, translational control via eIF4E acts as a convergence point for hyperactive signalling pathways to promote tumorigenesis. Consequently, recent works have aimed to target these pathways and ultimately the translational machinery for cancer therapy.
format Online
Article
Text
id pubmed-4613458
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-46134582015-10-23 Signalling to eIF4E in cancer Siddiqui, Nadeem Sonenberg, Nahum Biochem Soc Trans Biochemical Society Awards Translational control plays a critical role in the regulation of gene expression in eukaryotes and affects many essential cellular processes, including proliferation, apoptosis and differentiation. Under most circumstances, translational control occurs at the initiation step at which the ribosome is recruited to the mRNA. The eukaryotic translation initiation factor 4E (eIF4E), as part of the eIF4F complex, interacts first with the mRNA and facilitates the recruitment of the 40S ribosomal subunit. The activity of eIF4E is regulated at many levels, most profoundly by two major signalling pathways: PI3K (phosphoinositide 3-kinase)/Akt (also known and Protein Kinase B, PKB)/mTOR (mechanistic/mammalian target of rapamycin) and Ras (rat sarcoma)/MAPK (mitogen-activated protein kinase)/Mnk (MAPK-interacting kinases). mTOR directly phosphorylates the 4E-BPs (eIF4E-binding proteins), which are inhibitors of eIF4E, to relieve translational suppression, whereas Mnk phosphorylates eIF4E to stimulate translation. Hyperactivation of these pathways occurs in the majority of cancers, which results in increased eIF4E activity. Thus, translational control via eIF4E acts as a convergence point for hyperactive signalling pathways to promote tumorigenesis. Consequently, recent works have aimed to target these pathways and ultimately the translational machinery for cancer therapy. Portland Press Ltd. 2015-10-09 2015-10-01 /pmc/articles/PMC4613458/ /pubmed/26517881 http://dx.doi.org/10.1042/BST20150126 Text en © 2015 Authors; published by Portland Press Limited
spellingShingle Biochemical Society Awards
Siddiqui, Nadeem
Sonenberg, Nahum
Signalling to eIF4E in cancer
title Signalling to eIF4E in cancer
title_full Signalling to eIF4E in cancer
title_fullStr Signalling to eIF4E in cancer
title_full_unstemmed Signalling to eIF4E in cancer
title_short Signalling to eIF4E in cancer
title_sort signalling to eif4e in cancer
topic Biochemical Society Awards
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613458/
https://www.ncbi.nlm.nih.gov/pubmed/26517881
http://dx.doi.org/10.1042/BST20150126
work_keys_str_mv AT siddiquinadeem signallingtoeif4eincancer
AT sonenbergnahum signallingtoeif4eincancer